HRMY Harmony Biosciences Holdings, Inc. · $33.77 Neutral — no clear edge中性 — 无明显优势 Terminal终端
Harmony Biosciences Holdings, Inc. · Health Care

HRMY

$33.77
Quality compounder优质复利股 Small cap小盘 $2B
Engine stance引擎立场2026-07-20
Neutral — no clear edge中性 — 无明显优势
The bottoming setup is not yet confirmed (price still below the 10-day average) and the 3-day/weekly momentum is rolling筑底形态尚未确认(价格仍位于 10 日均线下方),且3 日/周线动量已开始掉头向下——动量在形态完成前已开始衰竭。等待价格收复 10 日均线且动量趋于稳定后再考虑建仓。
Open in Terminal打开终端 All coverage所有股票 Data through数据截至 2026-07-20 · regenerated nightly每日更新

Key Statistics关键统计

Price价格
$33.77
16.6% below 52-week high低于52周高点 16.6%
Market Cap市值
$2B
Normal volume正常成交量
P/E Ratio市盈率
12.3x
28.9x sector median
Beta贝塔
0.53
Moves about 0.5x the market波动幅度约为市场的 0.5 倍
RSI (14)RSI(14)
43
Neutral zone中性区域
Next Earnings下次财报
2026-08-04 (16d)
Volatility Rank波动率分位
63th pctile
hist. vol. percentile历史波动率分位数
Short Interest空头兴趣
8.0% of float

Performance价格表现

Period周期 HRMY S&P 500vs Index对比指数
1 Week近1周 -8.3% -1.5% Lagged the index by 6.8 points落后指数 6.8 个百分点
1 Month近1月 +0.0% +0.6% In line with the index与指数基本持平
3 Months近3月 +12.6% +4.7% Beat the index by 7.9 points跑赢指数 7.9 个百分点
6 Months近6月 -6.8% +7.8% Lagged the index by 14.6 points落后指数 14.6 个百分点
Year to date年初至今 -9.7% +9.1% Lagged the index by 18.8 points落后指数 18.8 个百分点
1 Year近1年 -7.3% +19.4% Lagged the index by 26.7 points落后指数 26.7 个百分点
3 Years近3年 -7.4% +69.4% Lagged the index by 76.8 points落后指数 76.8 个百分点

Technicals技术面

RSI (14)RSI(14) 43 Neutral zone中性区域
vs 50-day相对50日均线 +1.2% vs 50-day avg
vs 200-day相对200日均线 +3.6% vs 200-day avg
Volatility rank波动率分位 63th percentile 分位
Engine reference levels — not advice引擎参考水平 — 非投资建议
Buy zone买入区间
$32.80
Don't chase above不追高于
$33.77
Stop止损
$33.28
Extended — wait for a pullback过度拉伸 — 等待回撤

Earnings财务业绩

16
days until next report天后公布财报
2026-08-04

Estimates being cut预期下调

Earnings call transcripts — coming soon财报电话会议记录 — 即将上线

Valuation估值

Multiple指标 HRMY Sector median行业中位 Cheaper than相对便宜
P/E (trailing)市盈率(历史) 12.28x 28.92
93%
P/B市净率 2.24x 3.52
70%
P/S市销率 2.24x 3.02
60%
Earnings yield盈利收益率 8.14% 2.72
96%
FCF yield自由现金流收益率 17.85% 3.94
99%
P/FCF市值/自由现金流 5.60x 22.42
98%
Analyst price targets — coming soon分析师目标价 — 即将上线

Financials财务数据

Revenue营业收入
$159.7M
2020
$305.4M
2021
$437.9M
2022
$582.0M
2023
$714.7M
2024
$868.5M
2025
5yr CAGR5年复合增速: 40.3%
Earnings Per Share每股收益
$-2.48
2020
$0.58
2021
$2.97
2022
$2.13
2023
$2.51
2024
$2.71
2025
Free Cash Flow自由现金流
-$3.0M
2020
$98.3M
2021
$144.3M
2022
$219.1M
2023
$218.7M
2024
$347.9M
2025
Margins利润率
Gross margin毛利率
77.2%
Operating margin营业利润率
24.0%
Net margin净利率
18.3%
FCF margin自由现金流利润率
40.1%
18.2%Return on Equity股本回报率
12.5%Return on Assets资产回报率
Leverage杠杆
Current ratio流动比率3.60
Capital Allocation资本配置
Stock-based comp股权薪酬$44.9M
Share count change (1y)股数变化(1年)+1.0%
Piotroski皮奥特罗斯基 5/9 Altman Z阿尔特曼Z: safe (4.9) Watch关注

Snapshot Gauges综合指标

Valuation vs Sector估值相对行业
Looks cheap vs sector相对行业偏便宜
Cheaper than 80% of its sector on blended multiples综合估值倍数低于行业内 80% 的公司
Beta市场敏感度
0.53×
0.2
Moves about 0.5× the market波动幅度约为市场的 0.5 倍
Financial Health财务健康
5/9
Altman阿尔特曼: safe
Adequate financial health财务健康状况一般
Dividend分红
Does not pay a dividend不派发股息

Why Is It Moving为何波动

Macro宏观 Long-duration name into a restrictive, rising-real-rate regime → rate headwind.长久期标的进入偏紧、实际利率上行的环境→利率逆风。
Positioning持仓 Insider cluster activity内部人集中交易
Technical技术面 HRMY daily MACD crossed downHRMY 日线MACD下穿

Ownership & Smart Money持仓与聪明钱

Insider activity内部人员活动: -$2.8M net (0 buyers, 2 sellers)-$2.8M 净值(0 买家,2 卖家)

Signal History信号历史

NEARING A HIGH → BOTTOMING接近高点 → 筑底中
BUY SETUP. Buyers rejected the 2026-06-18 low (swing low printed) but price hasn't reclaimed its 10-day average — first box ticked, not all买入预备。买方拒绝了 2026-06-18 的低点(摆动低点已现),但价格尚未收复 10 日均线——第一项条件达成,并非全部
TURN SIGNALED BOTTOMING
Jul 13, 2026
HRMY daily MACD crossed downHRMY 日线MACD下穿
The daily MACD histogram turned negative — fast and noisy, context rather than a standalone trigger. $35.54.日线MACD柱状图转负 — 快速且嘈杂,仅作背景。$35.54。
Jul 7, 2026
BOTTOMING → NEARING A HIGH筑底中 → 接近高点
TAKE PROFITS止盈
Jul 7, 2026
HRMY RSI reached overboughtHRMY RSI进入超买
RSI(14) crossed above 70 — stretched to the upside; context, not a timing trigger alone. $38.26.RSI(14)上穿70 — 上行过度;仅作背景,单独不构成择时。$38.26。
Jul 6, 2026
NEARING A HIGH → BOTTOMING接近高点 → 筑底中
BUY SETUP买入预备
Jul 2, 2026
BOTTOMING → NEARING A HIGH筑底中 → 接近高点
TAKE PROFITS止盈
Jul 2, 2026
HRMY RSI reached overboughtHRMY RSI进入超买
RSI(14) crossed above 70 — stretched to the upside; context, not a timing trigger alone. $37.26.RSI(14)上穿70 — 上行过度;仅作背景,单独不构成择时。$37.26。
Jul 1, 2026
Golden cross on HRMYHRMY 金叉
The 50-day average crossed above the 200-day — a slow, widely-watched bullish trend signal. $36.00.50日均线上穿200日均线 — 一个滞后但广受关注的看多趋势信号。$36.00。
Jun 29, 2026
UPTREND → BOTTOMING上涨趋势 → 筑底中
BUY SETUP买入预备
Jun 26, 2026
HRMY daily MACD crossed upHRMY 日线MACD上穿
The daily MACD histogram turned positive — fast and noisy, context rather than a standalone trigger. $35.47.日线MACD柱状图转正 — 快速且嘈杂,仅作背景。$35.47。

Showing last 15 of显示最近15条,共 244 signals条信号

Factor Profile因子特征

Composite factor score综合因子得分: 0.38
Value价值
+0.3
Profitability盈利能力
+1.2
Quality质量
+1.8
Investment资本投入
-1.1
Low volatility低波动
-0.2
Low market beta低市场敏感度
+0.4
Earnings quality盈利质量
+2.0
Short interest空头兴趣
-0.8

Company Profile公司档案

Watch items — what could change the thesis关注项 — 可能改变论点的因素
  • Margin compression despite revenue growth
Get the full picture获取完整视图
Nightly signals, options flow, and factor analysis across all S&P 500 names.每日更新的信号、期权资金流向和因子分析,覆盖所有标普500成分股。